28. Green JB, Lane WS, Bergenstal RM, et al. Insulin Pump Settings Associated with Degree of Glycemic Improvement in Adults with Type 1 Diabetes Using Sensor-Augmented Pump Therapy. Presented at: Diabetes Technology Meeting; November 11-13, 2010; Bethesda, MD. Abstract A51.
29. Buse JB, Kidva YC, Guthrie RA, et al. Assessment of glycemic variability and CD40 ligand in the STAR 3 Study. Presented at: American Diabetes Association Scientific Sessions; June 2, 2011; San Diego, CA. Abstract 0923-P.
30. Hirsch IB. Algorithms for care in adults using continuous glucose monitoring. J Diabetes Sci Technol. 2007;1(1):126-129.
31. Wolpert HA. Continuous glucose monitoring: coming of age (editorial). N Engl J Med. 2010;363(4):383-384.
32. Wiegand S, Raile K, Reinehr T, et al; DPV-Wiss Study Group. Daily insulin requirement of children and adolescents with type 1 diabetes: effect of age, body mass index and mode of therapy. Eur J Endocrinol. 2008;158(4):543-549.
33. Hanas R, Ludvigsson J. Hypoglycemia and ketoacidosis with insulin pump therapy in children and adolescents. Pediatr Diabetes. 2006;7 suppl 4:32-38.
34. Unger J. A primary care approach to continuous subcutaneous insulin infusion. Clin Diabetes. 1999;17(3). http://journal.diabetes.org/clinicaldiabetes/V17N31999/Pg113.htm. Accessed October 21, 2011.